ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,921 | +388.8% | 70,791 | +454.0% | 0.16% | +323.1% |
| Q2 2023 | $393 | -16.6% | 12,779 | -2.2% | 0.04% | -17.0% |
| Q1 2023 | $471 | -99.9% | 13,069 | +1.5% | 0.05% | -42.0% |
| Q2 2022 | $541,000 | +72.8% | 12,874 | +63.9% | 0.08% | +107.7% |
| Q4 2021 | $313,000 | +2.6% | 7,857 | +5.6% | 0.04% | +14.7% |
| Q2 2021 | $305,000 | +29.8% | 7,440 | +58.3% | 0.03% | -10.5% |
| Q4 2020 | $235,000 | – | 4,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |